A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
pharmaceutical giant Moderna said its COVID-19 vaccine protects against two new variants of the coronavirus. The company said the vaccine triggered an immune response to "all key emerging variants," including those first identified in the UK and South Africa. The researchers looked...
Moderna launches COVID booster campaignHollan, MikePatient Care (Online)
Moderna is gearing up to halve the dose of its COVID-19 vaccine, the US drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children. It has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, ...
Nov 19, 2021Moderna Announces FDA Authorization of Booster Dose of COVID-19 Vaccine in the U.S. for Adults 18 Years and Older Nov 15, 2021Health Canada Authorizes Booster Dose of Moderna’s COVID-19 Vaccine in Individuals 18 Years of Age and Older ...
CAMBRIDGE (CBS) -- The FDA on Fridayauthorized Moderna and Pfizer's COVID vaccine booster shotsfor all adults 18 and older. A few hours later, CDC vaccine advisers voted unanimously to recommend allowing the booster shots for all, and CDC Director Rochelle Walensky endorsed the advisory committe...
After some of the CDC's advisers voiced concerns over Moderna's decision to use one vial for two different dose sizes, the company defended the move by citing the need to roll out booster shots in "the context of the pandemic." The company was still mulling changes to the vaccine's pack...
In the U.S., booster shots will soon be available for those who got the Moderna and Pfizer COVID-19 vaccines. But for those who got the single-shot Johnson & Johnson, many are still wondering what’s next. Mark Niu reports. Check out The China Report, our new weekly...
Moderna's booster will come at half the dose of the original two shots. As for recipients of the single-shot J&J vaccine, a COVID-19 booster is recommended for everyone at least two months after their vaccination. That's because the J&J vaccine hasn't proved as protective as the tw...
During anAxios COVID-19 vaccine eventon May 19, both the CEO of Moderna and the CEO of Pfizer said that depending on the research being done on the efficacy and longevity of the vaccines, a booster shot could be needed between either eight to 12 months after the recipient’s initial...